Table 1.
Parameter | STEMI Pts, n = 49 | Adverse remodelling, n = 18 (37%) | Non‐adverse remodelling, n = 31 (63%) | P |
---|---|---|---|---|
Age (years) | 57 ± 10 | 59 ± 11 | 56 ± 10 | 0.726 |
Weight (kg) | 80 ± 10 | 79 ± 11 | 81 ± 9 | 0.811 |
Height (cm) | 172 ± 6 | 173 ± 5 | 172 ± 7 | 0.593 |
BMI (kg/m2) | 27 ± 3 | 26 ± 3 | 25 ± 2 | 0.689 |
cTnI peak (ng/L) | 44 ± 75 | 44 ± 86 | 44 ± 71 | 0.754 |
SBP pre‐PCI (mmHg) | 124 ± 17 | 120 ± 19 | 126 ± 16 | 0.725 |
DBP pre‐PCI (mmHg) | 76 ± 9 | 72 ± 12 | 77 ± 7 | 0.411 |
HR pre‐PCI (bpm) | 73 ± 9 | 71 ± 8 | 74 ± 9 | 0.434 |
Door‐to‐balloon (min) | 184 ± 286 | 135 ± 174 | 212 ± 334 | 0.471 |
Time‐to‐PCI (min) | 248 ± 837 | 274 ± 246 | 247 ± 1,000 | 0.754 |
Male sex, n (%) | 46 (94%) | 17 (94%) | 29 (94%) | 0.679 |
Diabetes, n (%) | 6 (12%) | 5 (28%) | 2(6%) | 0.08 |
Hypertension, n (%) | 31 (63%) | 8 (44%) | 24 (77%) | 0.047 |
Family history for CAD, n (%) | 27 (55%) | 10 (56%) | 16 (52%) | 0.74 |
Active smoker, n (%) | 25 (51%) | 8 (44%) | 17 (55%) | 0.69 |
Dyslipidaemia, n (%) | 26 (53%) | 6 (33%) | 17(55%) | 0.188 |
Prodromal angina, n (%) | 9 (18%) | 6 (33%) | 3 (10%) | 0.065 |
Killip class 1, n (%) | 42 (86%) | 16 (89%) | 25 (81%) | 0.311 |
Killip class 2, n (%) | 7 (14%) | 1 (5%) | 6 (19%) | |
Anterior STEMI, n (%) | 31 (63%) | 13 (72%) | 18 (58%) | 0.305 |
Non‐anterior STEMI, n (%) | 18 (37%) | 5 (28%) | 13 (42%) | |
RCA dominant, n (%) | 26 (53%) | 15 (83%) | 29 (94%) | 0.362 |
TIMI flow grade 0/1 pre‐PCI, n (%) | 48 (98%) | 18 (100%) | 29 (94%) | 0.745 |
TIMI flow grade 2/3 pre‐PCI, n (%) | 1 (2%) | 0 (0%) | 2 (6%) | |
TIMI flow grade 0/1 post‐PCI, n (%) | 0 (0%) | 0 (0%) | 0 (0%) | 0.99 |
TIMI flow grade 2/3 post‐PCI, n (%) | 49 (100%) | 18 (100%) | 31 (100%) |
BMI, body mass index; CAD, coronary artery disease; CKMB, creatine kinase MB; cTnI, cardiac Troponin I; DPB, diastolic blood pressure; HR, heart rate; PCI, percutaneous coronary intervention; RCA, right coronary artery; SBP, systolic blood pressure; STEMI, segment elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction.